Search alternatives:
point decrease » point increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
761
-
762
-
763
-
764
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
765
-
766
Dopamine decreases the refractive power in the lens periphery.
Published 2013“…Positive ΔBCD values indicate a decrease in refractive power <i>i.e.</i> an increase in BCD in the treated lens compared with the corresponding control lens from the same animal. …”
-
767
-
768
-
769
-
770
-
771
Nilotinib decreases viability and proliferation of HEI-193 cells in a dose-dependent manner.
Published 2013“…Shown, mean value of six technical replicates. *denotes significant value (<i>p</i><0.05), **denotes significant value (p<0.005) (A) Nilotinib decreased absorbance on MTS viability assay in both growth conditions. …”
-
772
-
773
-
774
-
775
-
776
Knockdown of <i>CPT1A</i> inactivates most of fatty acid oxidation (FAO) and decreases cellular proliferation.
Published 2018“…<p>(A) Isotopologue distribution pattern of citrate in BT549 cells with scrambled small interfering RNA (siRNA) (scrambled, black) or after <i>CPT1A</i> knockdown (KD, red). …”
-
777
-
778
Laquinimod prevents EAE and decreases encephalitogenicity of T cells.
Published 2012“…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”
-
779
-
780